Skip to main content
Clinical Trials/EUCTR2016-004755-75-FR
EUCTR2016-004755-75-FR
Active, not recruiting
Phase 1

Intra articular injection of microfat and platelet-rich plasma in the treatment of knee osteoarthritis : a pilot study - MICROPREP

Clinique Juge0 sites30 target enrollmentFebruary 20, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Clinique Juge
Enrollment
30
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 20, 2017
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Clinique Juge

Eligibility Criteria

Inclusion Criteria

  • 1\. Males and females between 20 to 65 years of age
  • 2\. Symptomatic knee osteoarthritis , ICRS grade 2, 3 ou 4
  • 3\. BMI between 20 to 30
  • 4\. Written informed consent, signed by patient or legal representative
  • (if patient unable to sign).
  • 5\.HB \> 10g/dl
  • 6\.Negative pregnancy test
  • 7\.Social security affiliated
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:

Exclusion Criteria

  • 1\.IRM contre\-indications: ocular loose bodies, pace maker, neurostimulateur, cochlear implant, vascular clips, mettalic cardiac valve
  • 2\.BMI \< 20
  • 3\.Thrombocytopenia \< 150 G/L
  • 4\.Thrombocytosis \> 450 G/L
  • 5\.Thrombopathy
  • 6\.TP \< 70%
  • 7\.TCA patient / witness rapport \> 1,20
  • 8\.Anaemia: HB \< 10g/dl
  • 9\. Positive serology VIH1 and 2, Agp24, Ac HCV, Ag HbS, AcHbc, Ac HTLV I and II, TPHA
  • 10\.Treatment by platelet inhibiting agent, aspirin, anti vitamin K completed more than 2 weeks before inclusion

Outcomes

Primary Outcomes

Not specified

Similar Trials